PON1
PON1 (paraoxonase 1, also known as ESA or PON) is a secreted hydrolase that breaks down organophosphate substrates, lactones and aromatic carboxylic acid esters. It circulates bound to high density lipoprotein particles and is linked to the protection of lipoproteins from oxidative modification. Browse Assay Genie's current range of PON1 research reagents below, or read on for the biology behind the target.
PON1 hydrolyses the toxic metabolites of a variety of organophosphorus insecticides. It can act on a broad spectrum of organophosphate substrates and lactones, as well as a number of aromatic carboxylic acid esters. The NCBI Gene summary describes lactonase and ester hydrolase activity, and notes that the enzyme hydrolyses thiolactones and xenobiotics, including paraoxon, a metabolite of the insecticide parathion.
The enzyme is synthesised in the kidney and liver and then secreted into the circulation, where it binds to high density lipoprotein (HDL) particles. In this setting PON1 mediates an enzymatic protection of low density lipoproteins against oxidative modification, and against the consequent series of events leading to atheroma formation. This makes the PON1 protein a frequent subject in studies of lipoprotein biology and xenobiotic metabolism.
The PON1 gene encodes a member of the paraoxonase family, and HGNC places it in the paraoxonase gene group. It sits in a cluster of three related paraoxonase genes on chromosome 7, alongside PON2 and PON3. Polymorphisms in this gene may be associated with coronary artery disease and diabetic retinopathy. The mouse and rat orthologs are both named Pon1, which allows comparative work in rodent models.
PON1 hydrolyses toxic metabolites of organophosphorus insecticides, including paraoxon, making it relevant to studies of pesticide metabolism.
PON1 binds HDL particles in the circulation and helps protect low density lipoproteins against oxidative modification.
Its role in limiting atheroma formation, and gene polymorphisms linked to coronary artery disease, make PON1 a target in cardiovascular research.
Polymorphisms in the PON1 gene may be associated with diabetic retinopathy, supporting its study in diabetes-related disease.
PON1 is a secreted enzyme that hydrolyses organophosphate substrates, lactones and aromatic carboxylic acid esters, including the toxic metabolites of organophosphorus insecticides. Bound to HDL, it also protects low density lipoproteins from oxidative modification, which is linked to atheroma formation.
The HGNC symbol is PON1, for paraoxonase 1. Aliases and previous symbols include ESA and PON. UniProt lists the protein as serum paraoxonase/arylesterase 1, reflecting its paraoxonase and arylesterase activities, and it belongs to the paraoxonase family.
Mouse and rat both carry a Pon1 ortholog; check the datasheet of any product for its validated reactivity. In humans, polymorphisms in the gene may be associated with coronary artery disease and diabetic retinopathy. PON1 lies in a cluster of three paraoxonase genes on chromosome 7.
Other members of the paraoxonase family encoded in the same chromosome 7 gene cluster as PON1.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P27169; product specifications from Assay Genie datasheets.